[go: up one dir, main page]

EE200100256A - Ravimi manustamise vahend, eriti progestiinide jaöstrogeenide manustamiseks - Google Patents

Ravimi manustamise vahend, eriti progestiinide jaöstrogeenide manustamiseks

Info

Publication number
EE200100256A
EE200100256A EEP200100256A EEP200100256A EE200100256A EE 200100256 A EE200100256 A EE 200100256A EE P200100256 A EEP200100256 A EE P200100256A EE P200100256 A EEP200100256 A EE P200100256A EE 200100256 A EE200100256 A EE 200100256A
Authority
EE
Estonia
Prior art keywords
oestrogens
progestins
administration
delivery device
drug delivery
Prior art date
Application number
EEP200100256A
Other languages
English (en)
Inventor
Markkula Tommi
Ala-Sorvari Juha
Jukarainen Harri
Lehtinen Matti
Ruohonen Jarkko
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE200100256A publication Critical patent/EE200100256A/et
Publication of EE05506B1 publication Critical patent/EE05506B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nanotechnology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
EEP200100256A 1998-11-12 1999-10-26 Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks EE05506B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/190,606 US6063395A (en) 1998-11-12 1998-11-12 Drug delivery device especially for the delivery of progestins and estrogens
PCT/FI1999/000887 WO2000028968A1 (en) 1998-11-12 1999-10-26 Drug delivery device, especially for the delivery of progestins and estrogens

Publications (2)

Publication Number Publication Date
EE200100256A true EE200100256A (et) 2002-12-16
EE05506B1 EE05506B1 (et) 2012-02-15

Family

ID=22702031

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100256A EE05506B1 (et) 1998-11-12 1999-10-26 Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks

Country Status (30)

Country Link
US (1) US6063395A (et)
EP (1) EP1128811B1 (et)
JP (1) JP2002529493A (et)
KR (1) KR100621426B1 (et)
CN (1) CN1168439C (et)
AR (1) AR021152A1 (et)
AT (1) ATE267004T1 (et)
AU (1) AU760302B2 (et)
BG (1) BG65042B1 (et)
BR (1) BR9915326B1 (et)
CA (1) CA2351068C (et)
CO (1) CO5271704A1 (et)
CZ (1) CZ301609B6 (et)
DE (1) DE69917477T2 (et)
DK (1) DK1128811T3 (et)
EE (1) EE05506B1 (et)
ES (1) ES2221454T3 (et)
HK (1) HK1041814B (et)
HU (1) HU226113B1 (et)
ID (1) ID29190A (et)
IL (2) IL142523A0 (et)
NO (1) NO332168B1 (et)
NZ (1) NZ511216A (et)
PE (1) PE20001041A1 (et)
PL (1) PL194876B1 (et)
PT (1) PT1128811E (et)
RU (1) RU2226387C2 (et)
SK (1) SK286730B6 (et)
WO (1) WO2000028968A1 (et)
ZA (1) ZA200103298B (et)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20060110424A1 (en) * 2000-03-24 2006-05-25 Lyles Mark B Ceramic and metal compositions
US7011841B2 (en) * 2000-03-24 2006-03-14 Mark B. Lyles High density porous materials
AU2001258442A1 (en) * 2000-05-10 2001-11-20 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
ATE311201T1 (de) * 2000-08-23 2005-12-15 Akzo Nobel Nv Testosteron-ester formulierung zur anwendung am menschen
DE20015416U1 (de) 2000-09-06 2000-12-14 Bachmann, Karl-Heinz, 78667 Villingendorf Intrauterine Vorrichtung mit einem oder mehreren Pharmakadepots und integrierten Stellmitteln zur Variation der Abgabedosis
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
RU2302883C2 (ru) * 2001-08-31 2007-07-20 Шеринг Ой Система доставки лекарств
US9993424B2 (en) * 2002-03-27 2018-06-12 Allergan Pharmaceuticals International Limited Intravaginal matrix drug delivery devices
EP1553899A4 (en) * 2002-10-22 2006-10-25 METHOD AND SYSTEM FOR INTRAVASCULAR DELIVERY OF THERAPEUTIC AGENTS
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
CA2525792C (en) 2003-05-15 2015-10-13 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CN103251449B (zh) 2005-10-13 2016-03-02 斯恩蒂斯有限公司 载药包装物
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
PL2062569T3 (pl) * 2007-11-22 2011-10-31 Bayer Oy Dopochwowy układ dostarczania leku
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
KR20140048321A (ko) 2008-02-04 2014-04-23 테바 위민즈 헬스 인코포레이티드 프로게스테론 함유 단일형 질내 링 및 그의 제조방법과 용도
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
EP2953678B1 (en) 2013-02-06 2020-03-25 Sillender, Mark Therapeutic substance transfer catheter
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
JP6456935B2 (ja) 2013-06-21 2019-01-23 デピュイ・シンセス・プロダクツ・インコーポレイテッド フィルム及び製造方法
US11096888B2 (en) * 2015-05-13 2021-08-24 Bayer Oy Long acting drug delivery device and its use in contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
US11666552B2 (en) * 2017-09-27 2023-06-06 Bayer Oy Method for modifying release of a therapeutically active agent from an elastomeric matrix
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
KR20250026781A (ko) * 2022-05-26 2025-02-25 인시그나 인크. 암퇘지 및 반추동물에서 발정의 예방
US11938140B2 (en) 2022-05-26 2024-03-26 Insigna Inc. Non-surgical prevention of boar taint and aggressive behavior

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
US5011692A (en) * 1985-12-28 1991-04-30 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
IT8702928A0 (it) * 1987-07-22 1987-07-22 Alga Di Giudici Angelamaria & Friggitrice con cestello rotante secondo un asse orizzontale.
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
ES2091924T3 (es) * 1990-04-02 1996-11-16 Procter & Gamble Composiciones polimericas absorbentes, en forma de particulas que contienen agregados entrecruzados entre particulas.
JPH07216233A (ja) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd フルオロシリコーンゴム組成物
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens

Also Published As

Publication number Publication date
HUP0104037A2 (hu) 2002-04-29
HUP0104037A3 (en) 2003-04-28
US6063395A (en) 2000-05-16
BR9915326B1 (pt) 2013-10-22
IL142523A0 (en) 2002-03-10
AU760302B2 (en) 2003-05-08
BG105501A (en) 2001-12-29
AR021152A1 (es) 2002-06-12
IL142523A (en) 2006-06-11
ES2221454T3 (es) 2004-12-16
DE69917477T2 (de) 2005-06-02
HK1041814A1 (en) 2002-07-26
ATE267004T1 (de) 2004-06-15
EP1128811B1 (en) 2004-05-19
PE20001041A1 (es) 2000-10-14
CO5271704A1 (es) 2003-04-30
CA2351068C (en) 2008-09-02
RU2226387C2 (ru) 2004-04-10
CZ20011569A3 (cs) 2001-10-17
KR100621426B1 (ko) 2006-09-13
NZ511216A (en) 2002-09-27
KR20010075700A (ko) 2001-08-09
SK5132001A3 (en) 2001-11-06
JP2002529493A (ja) 2002-09-10
DE69917477D1 (de) 2004-06-24
ZA200103298B (en) 2001-10-25
EE05506B1 (et) 2012-02-15
BR9915326A (pt) 2001-10-09
PL348113A1 (en) 2002-05-06
NO20012047L (no) 2001-06-28
CZ301609B6 (cs) 2010-04-28
DK1128811T3 (da) 2004-09-27
BG65042B1 (bg) 2007-01-31
WO2000028968A1 (en) 2000-05-25
EP1128811A1 (en) 2001-09-05
NO20012047D0 (no) 2001-04-26
NO332168B1 (no) 2012-07-09
PT1128811E (pt) 2004-09-30
CN1326337A (zh) 2001-12-12
CN1168439C (zh) 2004-09-29
HK1041814B (zh) 2005-04-29
CA2351068A1 (en) 2000-05-25
PL194876B1 (pl) 2007-07-31
SK286730B6 (sk) 2009-04-06
AU1048800A (en) 2000-06-05
ID29190A (id) 2001-08-09
HU226113B1 (en) 2008-04-28

Similar Documents

Publication Publication Date Title
EE200100256A (et) Ravimi manustamise vahend, eriti progestiinide jaöstrogeenide manustamiseks
CY2021020I2 (el) Συστημα παραδοσης φαρμακων που αποτελειται απο τετραϋδροξυλιοποιημενο οιστρογονο για χρηση στην ορμονικη αντισυλληψη
EP1073490A4 (en) DEVICE FOR DISCHARGING A MEDICINE AND RELATED METHODS
DK1037667T3 (da) Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
DE60038304D1 (de) Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
CY2009015I1 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
ATE289500T1 (de) Ophtalmologische medikamentenzuführvorrichtung
DE50015812D1 (de) Vorratssystem für arzneimittel in pulverform und damit ausgestatteter inhalator
DK1473003T3 (da) Lægemiddeladministrationsanordning
AP2000001920A0 (en) Improvements in drug delivery device
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
EP1036573A4 (en) DEVICE FOR ADMINISTERING A SUBSTANCE THROUGH THE SKIN OR A MUCUTINE
ATE265852T1 (de) Geschmackskaschierte flüssige arzneizubereitungen
EE200200160A (et) 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid
DK1242012T3 (da) Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
AU1897199A (en) Use of formoterol in medicament for inflammation/allergy in upper airways
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
FI990977A7 (fi) Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen
IT1304899B1 (it) Metodo e dispositivo per la somministrazione di farmaci
EE9700021A (et) Fibriinile mõju avaldav monoklooniline antikeha kasutamiseks tromboosivastases ravis, farmatseutilised kompositsioonid ja ravimaine
HK1032014A (en) Improved drug delivery device and methods therefor
UA733S (uk) Внутріматковий протизаплідний засіб та пристрій для його введення
GB9713360D0 (en) Intravaginal drug delivery device

Legal Events

Date Code Title Description
HC1A Change of owner name
HC1A Change of owner name

Free format text: FORMER NAME: SCHERING OY

MM4A Lapsed by not paying the annual fees

Effective date: 20171026